Shaanxi Hanjiang Pharmaceutical Group Co. Ltd
Shaanxi Hanjiang Pharmaceutical Group Co. Ltd., commonly referred to as Hanjiang Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Shaanxi Province, China. Established in 1996, the company has made significant strides in the development and production of high-quality pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong focus on research and development, Hanjiang Pharmaceutical has carved a niche in the production of traditional Chinese medicine and modern pharmaceuticals, catering to both domestic and international markets. The company is recognised for its commitment to quality and innovation, which has solidified its position as a trusted supplier in the healthcare sector. Notable achievements include various certifications and partnerships that enhance its market presence and operational capabilities.
DitchCarbon Score
How does Shaanxi Hanjiang Pharmaceutical Group Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shaanxi Hanjiang Pharmaceutical Group Co. Ltd's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shaanxi Hanjiang Pharmaceutical Group Co. Ltd's reported carbon emissions
Shaanxi Hanjiang Pharmaceutical Group Co. Ltd, headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As a current subsidiary, Shaanxi Hanjiang Pharmaceutical Group Co. Ltd's climate initiatives and emissions data may be influenced by its corporate family structure. However, no specific data or targets have been cascaded from a parent organization or related entities. The absence of emissions reporting and reduction initiatives places the company in a context where it may need to enhance its climate strategy to align with industry standards and expectations for sustainability. In summary, while Shaanxi Hanjiang Pharmaceutical Group Co. Ltd has not disclosed any emissions data or climate commitments, the company may benefit from developing a comprehensive approach to carbon management and sustainability in the pharmaceutical sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shaanxi Hanjiang Pharmaceutical Group Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
